O. Sencan Et Al. , "The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.," European journal of cancer care , vol.17, no.1, pp.26-32, 2008
Sencan, O. Et Al. 2008. The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.. European journal of cancer care , vol.17, no.1 , 26-32.
Sencan, O., Buyukcelik, A., Yalcin, B., Boruban, M. C., AKBULUT, H., DEMİRKAZIK, A., ... Senler, F.(2008). The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.. European journal of cancer care , vol.17, no.1, 26-32.
Sencan, O. Et Al. "The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.," European journal of cancer care , vol.17, no.1, 26-32, 2008
Sencan, O. Et Al. "The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.." European journal of cancer care , vol.17, no.1, pp.26-32, 2008
Sencan, O. Et Al. (2008) . "The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.." European journal of cancer care , vol.17, no.1, pp.26-32.
@article{article, author={O. Sencan Et Al. }, title={The symptomatic benefit (the clinical benefit response) from the second-line chemotherapy in patients with advanced gastric adenocarcinoma.}, journal={European journal of cancer care}, year=2008, pages={26-32} }